FDA Gives Fast Track Status to Proteostasis’ Triple Combo Treatment for CF
cystic fibrosis, News
The U.S. Food and Drug Administration has granted Fast Track Designation to Proteostasis Therapeutics’ triple combo treatment program for cystic fibrosis. The program includes the company’s amplifier, corrector, and ... Read more